Multiple endocrine neoplasia type 1 CT

Revision as of 20:31, 9 September 2015 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Multiple endocrine neoplasia type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple endocrine neoplasia type 1 CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 1 CT

CDC on Multiple endocrine neoplasia type 1 CT

Multiple endocrine neoplasia type 1 CT in the news

Blogs on Multiple endocrine neoplasia type 1 CT

Directions to Hospitals Treating Multiple endocrine neoplasia type 1

Risk calculators and risk factors for Multiple endocrine neoplasia type 1 CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

CT

Gastrointestinal Neuroendocrine Tumors

  • Used for suspected gastric, enteric and pancreatic NETS pre and post IV iodinated contrast.
  • Bowel distension with fluid, either by oral intake (CT enterography) or via an Nasojejunal tube (CT enteroclysis) improves detection of primary GI NETS .

Zollinger-Ellison Syndrome

  • Negative contrast may be used to distend the stomach
  • Thickened rugal folds
  • Multiple gastric nodules/masses[1][2]

Insulinoma[3]

  • They tend to be hyper-attenuating on arterial phase so arterial or pancreatic phased imaging may aid in better detection 6-7. Some may show calcification.

Pancreatic Islet Cell Tumors

  • Multiphase contrast enhanced thin slice cross-sectional imaging is ideal. Tumours tend to be smaller and hypervascular and may be calcified, and may be cystic.

Gastrinoma[4]

  • Gastinomas are usually malignant and as they are frequently multiple and often extrapancreatic (90% located in the gastrinoma triangle) they can be difficult to locate. As such multiphase contrast enhanced thin slice cross-sectional imaging is ideal.
  • Tumor size is variable, but pancreatic lesions average 3-4 cm.
  • The lesions are often hypervascular, so they may be visible on arterial phase CT and angiography.

Glucagonoma[5]

  • Tumor size is variable, but most are large and have metastasized at the time of diagnosis. Most are located in the distal pancreas and are vascular.
  • Tumors may be solid or contain central low-attenuation areas on CT.

Reference

  1. King AD, Ko GT, Yeung VT, Chow CC, Griffith J, Cockram CS (1998). "Dual phase spiral CT in the detection of small insulinomas of the pancreas". Br J Radiol. 71 (841): 20–3. doi:10.1259/bjr.71.841.9534694. PMID 9534694.
  2. Fidler JL, Fletcher JG, Reading CC, Andrews JC, Thompson GB, Grant CS; et al. (2003). "Preoperative detection of pancreatic insulinomas on multiphasic helical CT". AJR Am J Roentgenol. 181 (3): 775–80. doi:10.2214/ajr.181.3.1810775. PMID 12933480.
  3. "Radiopedia2015 Insulinoma [Dr Yuranga Weerakkody and Dr Frank Gaillard]".
  4. "Radiopedia2015 Gastrinoma [Dr Frank Gaillard]".
  5. "Radiopedia2015 Glucagonoma [Dr Yuranga Weerakkody and Dr Frank Gaillard]".